Gold nanoparticles enhanced electroporation for mammalian cell transfection

Journal of Biomedical Nanotechnology

Volumn 10, Issue 6, 2014, Pages 982-992

  Zu, Yingbo ^a,b   Huang, Shuyan ^a   Liao, Wei Ching ^c   Lu, Yang ^a,b   Wang, Shengnian ^a,b  

^a Louisiana Tech University   (United States)

^b LOUISIANA TECH UNIVERSITY   (United States)

^c Ohio State University   (United States)

Author keywords

Electroporation; Gene delivery; Gold nanoparticles; Transfection enhancement

Indexed keywords

CELL MEMBRANES; CYTOLOGY; DRUG THERAPY; EFFICIENCY; GENE TRANSFER; GOLD; MEDICAL APPLICATIONS; METAL NANOPARTICLES; MICROELECTRODES; NUCLEIC ACIDS;

BIOMEDICAL APPLICATIONS; ELECTROPORATION; FLOW-THROUGH SYSTEMS; GENE DELIVERY; GOLD NANOPARTICLES; NON-VIRAL GENE DELIVERY; THERAPEUTIC MATERIALS; TRANSFECTION EFFICIENCY;

MOLECULAR BIOLOGY;

DNA; GOLD NANOPARTICLE; GREEN FLUORESCENT PROTEIN; TRANSFERRIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRAIN K 562; CELL VIABILITY; CONTROLLED STUDY; DNA PROBE; ELECTROPORATION; GENE TARGETING; GENETIC TRANSFECTION; IN VITRO STUDY; LEUKEMIA CELL; LYMPHOBLAST; MAMMAL CELL; MICROELECTRODE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PLASMID;

DNA; ELECTROMAGNETIC FIELDS; ELECTROPORATION; GOLD; HUMANS; K562 CELLS; METAL NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; TRANSFECTION;

EID: 84898439648     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1797     Document Type: Article

References (51)

1. D. Luo and W. M. Saltzman, Synthetic DNA delivery systems. Nat. Biotechnol. 18, 33 (2000).
2. N. S. Templeton (ed.), Gene and Cell Therapy: Therapeutic Mechanism and Strategies, 2nd edn., Marcel Dekker, New York (2004).
3. D. H. Hamer and P. Leder, Splicing and the formation of stable RNA. Cell 18, 1299 (1979).
4. R. C. Mulligan, B. H. Howard, and P. Berg, Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome. Nature 277, 108 (1979).
5. I. M. Verma and N. Somia, Gene therapy - promises, problems and prospects. Nature 389, 239 (1997).
6. E. Marshall, Gene therapy death prompts review of adenovirus vector. Science 286, 2244 (1999).
7. U. Lungwitz, M. Breunig, T. Blunk, and A. Gopferich, Polyethylenimine- based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 3, 137 (1996).
8. O. Boussif, M. A. Zanta, and J. P. Behr, Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther. 3, 1074 (1996).
9. P. L. Felgner, Y. Barenholz, J. P. Behr, S. H. Cheng, P. Cullis, L. Huang, J. A. Jessee, L. Seymour, F. Szoka, A. R. Thierry, E. Wagner, and G. Wu, Nomenclature for synthetic gene delivery systems. Hum. Gene Ther. 8, 511 (1997).
10. S. Li and Z. Ma, Nonviral gene therapy. Curr. Gene Ther. 1, 201 (2001).
11. B. Yu, X. Zhao, L. J. Lee, and R. J. Lee, Targeted delivery systems for oligonucleotide therapeutics. AAPS. J. 11, 195 (2009).
12. F. Schakowski, P. Buttgereit, M. Mazur, A. Marten, B. Schottker, M. Gorschluter, and I. Schmidt-Wolf, Novel non-viral method for transfection of primary leukemia cells and cell lines. Generic Vaccine and Therapy 2, 1 (2004).
13. C. Patra, R. Bhattacharya, D. Mukhopadhyay, and P. Mukherjee, Application of gold nanoparticles for targeted therapy in cancer. J. Biomed. Nanotechnol. 4, 99 (2008).
14. C. Cai, T. Gao, H. Hong, and J. Sun, Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol. Sci. App. 1, 17 (2008).
15. S. Guo, Y. Huang, Q. Jiang, Y. Sun, L. Deng, Z. Liang, Q. Du, J. Zing, Y. Zhao, P. C. Wang, A. Dong, and X. J. Liang, Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano 4, 5505 (2010).
16. A. Elbakry, A. Zaky, R. Liebl, R. Rachel, A. Goepferich, and M. Breunig, Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett. 9, 2059 (2009).
17. J. A. Viator, S. Gupta, B. S. Goldschmidt, K. Bhattacharyya, R. Kannan, R. Shukla, P. S. Dale, E. Boote, and K. V. Katti, Detection of gold nanoparticle enhanced prostate cancer cells using photoacoustic flowmetry with optical reflectance. J. Biomed. Nanotechnol. 6, 1 (2010).
18. J. I. Cutler, E. Auyeung, and C. A. Mirkin, Spherical nucleic acids. J. Am. Chem. Soc. 134, 1376 (2012).
19. A. Verma, O. Uzun, Y. Hu, Y. Hu, H.-S. Han, N. Watson, S. Chen, D. J. Irvine, and F. Stellacci, Surface structure-regulated cell membrane penetration by monolayer protected nanoparticles. Nat. Mater. 7, 588 (2008).
20. M. Ahmed, Z. Deng, and R. Narain, Study of transfection efficiencies of cationic glyconanoparticles of different sizes in human cell line. ACS Appl. Mater. Interfaces 1, 1980 (2009).
21. N. S. Yang and W. H. Sun, Gene gun and other non-viral approaches for cancer gene therapy. Nat. Med. 1, 481 (1995).
22. A. K. Salem, P. C. Searson, and K. W. Leong, Multifunctional nanorods for gene delivery. Nat. Material 2, 668 (2003).
23. E. Neumann, M. Schaefer-Ridder, Y. Wang, and P. H. Hofschneider, Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO. J. 1, 841 (1982).
24. F. Toneguzzo and A. Keating, Stable expression of selectable genes introduced into human hematopoietic stem cells by electric field-mediated DNA transfer. Proc. Natl. Acad. Sci. U.S.A. 83, 3496 (1986).
25. D. C. Chang, B. M. Chassy, and J. A. Saunder (eds.), Guide to electroporation and electrofusion, Academic: San Diego, CA (1992).
26. J. Teissie and M. P. Rols, An experimental evaluation of the critical potential difference inducing cell membrane electropermeabilization. Biophys. J. 65, 409 (1993).
27. E. Neumann and S. Kakorin, Digression on membrane electroporation and electroporative delivery of drugs and genes. Radiol. Oncol. 32, 7 (1998).
28. J. Gehl, Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research. Acta. Physiol. Scand. 177, 437 (2003).
29. P. Lorenz, U. Harnack, and R. Morgenstern, Efficient gene transfer into murine embryonic stem cells by nucleofection. Biotechnol. Lett. 26, 1589 (2004).
30. Y. Huang and B. Rubinsky, Flow-through micro-electroporation chip for high efficiency single-cell genetic manipulation. Sens. Actuators A: Phys. 104, 205 (2003).
31. Y. C. Lin, M. Li, and C. C. Wu, Simulation and experimental demonstration of the electric field assisted electroporation microchip for in vitro gene delivery enhancement. Lab Chip 4, 104 (2004).
32. H. Lu, M. A. Schmidt, and K. F. Jensen, A microfluidic electroporation device for cell lysis. Lab Chip 5, 23 (2005).
33. M. Khine, A. Lau, C. Ionescu-Zanetti, J. Seo, and L. P. Lee, A single cell electroporation chip. Lab Chip 5, 38 (2005).
34. H. Y. Wang and C. Lu, Electroporation of mammalian cells in a microfluidic channel with geometric variation. Anal. Chem. 78, 5158 (2006).
35. H. Y. Wang and C. Lu, High-throughput and real-time study of single cell electroporation using microfluidics: Effect of medium osmolarity. Biotechnol. Bioeng. 95, 1116 (2006).
36. Z. Fei, S. Wang, Y. Xie, B. E. Henslee, C. G. Koh, and L. J. Lee, Gene transfection of mammalian cells using membrane sandwich electroporation. Anal. Chem. 79, 5719 (2007).
37. J. A. Kim, K. Cho, Y. S. Shin, N. Jung, C. Chung, and J. K. Chang, A multi-channel electroporation microchip for gene transfection in mammalian cells. Biosens. Bioelectron. 22, 3273 (2007).
38. A. Valero, J. N. Post, J. W. van Nieuwkasteele, P. M. T. Braak, W. Kruijer, and A. van den Berg, Gene transfer and protein dynamics in stem cells using single cell electroporation in a microfluidic device. Lab Chip 8, 62 (2008).
39. H. Y. Wang and C. Lu, Microfluidic electroporation for delivery of small molecules and genes into cells using a common DC power supply. Biotechnol. Bioeng. 100, 579 (2008).
40. E. G. Guignet and T. Meyer, Suspended-drop electroporation for high-throughput delivery of biomolecules into cells. Nat. Methods 5, 393 (2008).
41. S. Wang, X. Zhang, W. Wang, and L. J. Lee, Semicontinuous flow electroporation chip for high-throughput transfection on mammalian cells. Anal. Chem. 81, 4414 (2009).
42. Z. Fei, X. Hu, H.-W. Choi, S. Wang, D. Farson, and L. J. Lee, Micronozzle array anhanced sandwich electroporation of embryonic stem cells. Anal. Chem. 82, 353 (2010).
43. T. Geng, Y. Zhan, H. Y. Wang, S. R. Witting, K. G. Cornetta, and C. Lu, Flow-through electroporation based on constant voltage for large-volume transfection of cells. J. Control Release 144, 91 (2010).
44. P. E. Boukany, A. Morss, W. C. Liao, B. Henslee, H. C. Jung, X. L. Zhang, B. Yu, X. M. Wang, Y. Wu, L. Li, K. L. Gao, X. Hu, X. Zhao, O. Hemminger, W. Lu, G. P. Lafyatis, and L. J. Lee, Nanochannel electroporation delivers precise amounts of biomolecules into living cells. Nat. Nanotechnol. 6, 747 (2011).
45. Z. W. Wei, D. Y. Zhao, X. M. Li, M. X. Wu, W. Wang, H. Huang, X. X. Wang, Q. Du, Z. C. Liang, and Z. H. Li, Laminar flow electroporation system for efficient DNA and siRNA delivery. Anal. Chem. 83, 5881 (2011).
46. S. Wang, X. Zhang, B. Yu, R. Lee, and L. J. Lee, Targeted nanoparticles enhanced flow electroporation of antisense oligonucleotides in leukemia cells. Biosens. Bioelectron. 26, 778 (2010).
47. D. A. Stewart, T. R. Gowrishankar, K. C. Smith, and J. C. Weaver, Cylindrical cell membranes in uniform applied electric fields: Validation of a transport lattice method. IEEE Trans. Biomed. Eng. 52, 1643 (2005).
48. Z. Fei, X. Hu, H.-W. Choi, S. Wang, D. Farson, and L. J. Lee, Micronozzle array anhanced sandwich electroporation of embryonic stem cells. Anal. Chem. 82, 353 (2010).
49. E. Wagner, D. Curiel, and M. Cotton, Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Adv. Drug Deliver Rev. 14, 113 (1994).
50. P. E. Laibinis, J. J. Hickman, M. S. Wrighton, and G. M. Whitesides, Orthogonal self-assembled monolayers: Alkanethiols on gold and alkane carboxylic acids on alumina. Science 245, 845 (1989).
51. X. Yang, C.-G. Koh, S. Liu, X. Pan, R. Santhanam, B. Yu, Y. Peng, J. Pang, S. Golan, Y. Talmon, J. Jin, N. Muthusamy, J. C. Byrd, K. K. Chan, L. J. Lee, G. Marcucci, and R. Lee, Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2. J. Mol. Pharmaceutics 6, 221 (2009).